Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2019-02-04Clinical Trial Update: RSV Disease in the Elderly
A completed ClinicalTrials.gov study sponsored by NIAID evaluating respiratory infections due to Respiratory Syncytial Virus in elderly pati…
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171 [Phase 1, Phase 2]
Phase 1/2 multicenter trial assessing safety, tolerability, and clinical activity of ALX-0171 in otherwise healthy infants and toddlers hosp…
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants [Phase 3]
Phase 3 trial assessing the efficacy and safety of Suptavumab (REGN2222) for preventing medically attended RSV infections in preterm infants…
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany
A completed prospective trial assessing palivizumab (Synagis) in high-risk children in Germany with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age [Phase 1]
Phase 1 trial assessing infectivity, safety, and immunogenicity of a recombinant live-attenuated RSV vaccine in RSV-seronegative infants age…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults [Phase 1]
A Phase 1 study assessing safety and antibody-inducing potential of an RSV vaccine in healthy adults; results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: ALX-0171 Safety Study in Adults With Hyperresponsive Airways [Phase 1]
Phase 1 safety study of ALX-0171 in adults with hyperresponsive airways infected with respiratory syncytial virus, conducted by Ablynx (a Sa…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers [Phase 1]
This Phase I trial evaluated single ascending dose and multiple dose regimens of ALX-0171 in healthy male volunteers and has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age [Phase 1]
Phase 1 trial assessing infectivity, safety, and immunogenicity of a recombinant live-attenuated RSV vaccine in seronegative infants; study …
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study [Phase 2]
This Phase 2 RSV viral challenge trial update reports safety, efficacy and pharmacokinetics data for BTA-C585.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Safety Study of Oral BTA9881 to Treat RSV Infection [Phase 1]
Phase 1 safety study of oral BTA9881 for Respiratory syncytial virus infection has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection [Phase 2]
Phase 2 trial updates on presatovir for hospitalized adults with RSV infection, focusing on efficacy, pharmacokinetics, and safety after stu…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract [Phase 2]
Phase 2 clinical trial update for Presatovir in hematopoietic cell transplant recipients with lower respiratory tract RSV infection.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
This completed trial update reports how RSV monoclonal antibody therapy was used and how compliant sites were with its administration for RS…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus [Phase 3]
Phase 3 study evaluating the safety and effectiveness of palivizumab in high-risk children for RSV infection in Russia and Belarus; the tria…
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults [Phase 1]
Phase 1 study evaluating the safety and immunogenicity of MEDI7510 in older adults with respiratory syncytial virus infection; results have …
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176 [Phase 1]
This update reports the completion of a Phase 1 open-label study evaluating the absorption, metabolism, excretion, and absolute bioavailabil…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating single and multiple doses of the RSV antiviral ALS-008176 in…
-
EMA guidance · 2017-10-30How to develop vaccines and medicines that prevent and treat respiratory syncytial virus (RSV) infection
EMA guidance outlining considerations for developing vaccines and medicines to prevent and treat respiratory syncytial virus (RSV) infection…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women [Phase 2]
Phase 2 safety, reactogenicity and immunogenicity study of different formulations of GSK's investigational RSV vaccine (GSK3003891A) in heal…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV) [Phase 1]
A Phase 1 intranasal challenge trial of respiratory syncytial virus in healthy adults sponsored by MedImmune was terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women [Phase 2]
Phase 2 safety and reactogenicity results for GSK's investigational RSV vaccine (GSK3003891A) in healthy women have been completed with resu…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Effect of Heliox on RSV Bronchiolitis [Phase 3]
A Phase 3 trial assessing the effect of heliox on respiratory syncytial virus bronchiolitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating the safety, reactogenicity and immunogenicity of GlaxoSmithK…
-
CLINICAL_TRIALS research · 2017-05-23Clinical Trial Update: An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants
This document reports the completion of an observational study sponsored by AstraZeneca examining respiratory syncytial virus hospitalizatio…